论文部分内容阅读
目的 :探讨甘利欣联合丹参对慢性肝炎肝纤维化的治疗作用。方法 :将 2 0 0例慢性乙型肝炎患者分为治疗组(予甘利欣加丹参治疗)、甘利欣组 (予甘利欣治疗 )和丹参组 (予丹参治疗 ) ,治疗前后检测各组肝功能及肝纤维化血清学指标。结果 :治疗组治疗后肝纤维化指标明显下降 ,与治疗前及甘利欣组、丹参组比较有明显差异 (P均 <0 .0 1 )。结论 :甘利欣联合丹参对慢性肝炎有明显的抗纤维化作用
Objective: To explore the therapeutic effect of Ganlixin combined with Salvia miltiorrhiza on liver fibrosis in chronic hepatitis. Methods: Two hundred and eighty patients with chronic hepatitis B were divided into treatment group (Salmonella Glycyrrhizin, Glycyrrhizin group) and Salvia miltiorrhiza group (Salvia group). Before and after treatment, liver function And liver fibrosis serological indicators. Results: The indexes of liver fibrosis in the treatment group decreased obviously, which were significantly different from those in the Glycyrrhiza group and the Salvia miltiorrhiza group before treatment (all P <0.01). Conclusion: Salvia miltiorrhiza combined with salvia miltiorrhiza have obvious anti-fibrosis effect on chronic hepatitis